regulatory

Are Compounded GLP-1 Medications Going Away in 2026?

Editorially reviewed March 2026
Share:

If you're on compounded semaglutide or tirzepatide, you've probably seen the headlines: the FDA is cracking down, and the future of compounded GLP-1 medications isn't clear. (See our semaglutide guide.)

This is what's actually going on, what it means for you, and what you can do about it.

What Changed

During the GLP-1 shortage of 2023-2024, the FDA let compounding pharmacies produce copies of semaglutide and tirzepatide under shortage rules. That made GLP-1 treatment accessible to people who couldn't get or afford the brand-name versions -- often at $150-$400/month instead of $1,000+. (See our tirzepatide guide.) (See our GLP-1 pricing guide.)

Now that brand-name supply has caught up, the FDA is pulling back on those allowances. The key developments:

  • Shortage declarations have been revised. With Novo Nordisk and Eli Lilly ramping production, the legal basis for compounding has narrowed.
  • The FDA has sent enforcement letters to compounding pharmacies and telehealth platforms selling compounded versions.
  • Grace periods are running out. Pharmacies given time to wind down are hitting their deadlines.
  • Court fights are ongoing. Several compounding pharmacies and trade groups are challenging the FDA in court.

What This Means for Patients

If you're currently taking compounded semaglutide or tirzepatide: (See our telehealth GLP-1 providers.)

  • Your current supply probably won't disappear overnight. Regulatory shifts take time, and legal battles can slow enforcement further.
  • Your pharmacy may pivot on its own. Many compounders are already moving toward other weight loss compounds or brand-name prescribing.
  • Don't stockpile. Compounded peptides have shelf-life limits and storage requirements that make hoarding risky and wasteful.
  • Start thinking about a backup plan. Talk to your provider now about alternatives -- don't wait until you're out.

Your Options Going Forward

1. Switch to Brand-Name Medication

Brand-name Wegovy and Zepbound are easier to get now than they were in 2024. The sticker price is steep ($1,000-$1,300/month), but there are real ways to bring that down:

  • Insurance -- coverage for weight loss indications is growing. See our insurance coverage guide.
  • Manufacturer savings cards -- both Novo Nordisk and Eli Lilly offer programs that can cut commercially-insured copays by a lot.
  • Medicare -- GLP-1 coverage is expanding in 2026. See our Medicare coverage guide.

2. Explore Oral GLP-1 Options

The oral semaglutide (Wegovy pill) launched in 2025 and is now at many pharmacies. Your insurance may cover it differently than the injectable, and some patients find the pricing works out better. (See our GLP-1 insurance coverage guide.) (See our savings calculator.)

3. Ask About Alternative Medications

Other weight loss drugs are still available and may fit your situation. Saxenda (liraglutide) is another GLP-1 option, and non-GLP-1 drugs like Contrave and Qsymia are prescribed at plenty of clinics. (See our liraglutide guide.)

4. Find a Clinic That Carries Multiple Options

What matters most right now is having a provider who can shift your treatment plan as things change. Clinics offering more than one medication -- not just a single compound or brand -- are best equipped to keep your treatment going without interruption.

How to Protect Yourself

No matter what happens with the regulations:

  1. Check your pharmacy. If you're using compounded meds, make sure your pharmacy is 503B-registered (not just 503A) and follows FDA manufacturing standards.
  2. Talk to your provider now. Don't wait for your supply to run out. Get ahead of it.
  3. Look into your insurance. Brand-name GLP-1 coverage has expanded a lot recently. Your plan may cover more than you'd guess.
  4. Be wary of miracle replacements. As compounded GLP-1s get harder to get, expect some companies to push unproven peptides and supplements as substitutes. Stick with FDA-approved medications from licensed providers.

Find a Provider Who Can Help You Navigate This

The GLP-1 market is shifting fast. STAT News covers the regulatory and pharmaceutical developments around compounding in real time — worth following if you want to stay informed. The best thing you can do is work with a provider who stays on top of the changes and can offer you more than one path forward.

Search our directory to find weight loss clinics with full GLP-1 programs. Filter by medication type to find providers offering what you need. Browse clinics in Las Vegas, Atlanta, Denver, and Indianapolis.

Find a weight loss clinic near you — compare providers, medications, and ratings.

Browse Clinics →
Looking for a GLP-1 Clinic?

Compare verified providers by medication, telehealth availability, and pricing across all 50 states.

Find Clinics →

Related Articles